- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 199.19M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.03B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $85.97M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $88.9M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $103.24M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $120.06M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $261.94M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $228.29M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.94B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.9B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $205.7M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $231.78M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.24B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.25B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 198.86M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $390K |
| Capex | Q1 2025 · Mar 31, 2024 | $55.29M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $43.81M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.04 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.04 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $18.86M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$8.48M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$26.6M |
| Revenue | Q1 2025 · Mar 31, 2024 | $46.15M |